Massachusetts-based joint devices maker Arthrosurface landed FDA clearance for its ToeMotion Total Toe fixation system, the company announced this month.
Launched during the AAOS conference in New Orleans, the ToeMotion Total Toe system aims to fix the joint and preserve bone without jeopardizing the stability of the toe.
The technology is based on Arthrosurface’s proprietary HemiCAP technology, used in shoulders, hips and knees. The toe fixation system provides implants on both sides of the joint rather than fusion, allowing continues movement of the toe while supporting its function.
Launching the new ToeMotion Total Toe system is just the beginning for Arthrosurface, which plans to release a slew of new technologies in coming months.
"The extremities market is providing an excellent opportunity for growth over the next several years. As such, we are targeting to launch another 5 extremity products along with the new ToeMotion system," CEO and co-founder Steve Ek said in prepared remarks. "Our platform technology for rock-solid immediate fixation and inlay arthroplasty has been proven to work on many different joints."
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.